Brady Family Wealth LLC Has $3.47 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Brady Family Wealth LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,852 shares of the healthcare conglomerate’s stock after purchasing an additional 236 shares during the quarter. Brady Family Wealth LLC’s holdings in UnitedHealth Group were worth $3,466,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter worth $27,000. Global Wealth Strategies & Associates raised its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $32,000. Quarry LP raised its position in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the third quarter worth approximately $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $543.21 on Thursday. The company has a market capitalization of $499.91 billion, a price-to-earnings ratio of 35.39, a PEG ratio of 1.42 and a beta of 0.62. The company has a 50-day moving average of $554.45 and a 200-day moving average of $563.12. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The company’s revenue was up 6.8% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on UNH shares. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. UBS Group lowered their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $626.79.

Check Out Our Latest Research Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.